Early research shows promise for therapeutics that delay type 2 diabetes
Survey finds global mistrust could weigh on vaccine rollout
13 January 2021Midwife’s research features in new national guidance on drinking during pregnancy
13 January 2021Early research shows promise for therapeutics that delay type 2 diabetes
Vanderbilt researchers have discovered a unique pathway that initiates islet β cell inflammation—a hallmark of type 2 diabetes—putting them a step closer to developing targeted therapeutics for the disease that affects one in 10 Americans.
